Anon.: Evaluation of a Hypocholesterolemia Agent. Dextrothyroxine Sodium (Choloxin), J. Am. Med. Assoc.208: 1014 (May 12) 1969. (R).
2.
BestM. M.DuncanC. H.: Effects of Clofibrate and Dextrothyroxine Singly and in Combination on Serum Lipids, Arch. Internal Med.118: 97–102 (Aug.) 1966. (OH).
3.
JonesR. J.CohenL.: Sodium Dextrothyroxine in Coronary Disease and Hypercholesteremia, Circulation24: 164 (Aug.) 1961. (OH).
4.
LangerT.LevyR. I.: Acute Muscular Syndrome, New Engl. J. Med.279: 856 (Oct. 17) 1968. (CH).
5.
OliverM. F.: Effect of Atromid and Ethyl Chlorophenoxyisobutyrate on Anticoagulant Requirements, Lancet1: 143, (Jan. 19) 1963. (OH).
6.
SchrogieJ. L.SolomonH. M.: Anticoagulant Response to Bishydroxycoumarin. II. Effect of D-thyroxine, Clofibrate and Norethandrolone, Clin. Pharmacol. Therap.8: 70 (July-Aug.) 1967. (OAH).
7.
SolomonH. M.SchrogieJ. J.: Change in Receptor Site Affinity: A Proposed Explanation for the Potentiating Effect of D-Thyroxine on the Anticoagulant Response to Warfarin, Ibid.8: 797 (Nov.-Dec.) 1967. (OH).
8.
WintersW. L.Jr.SoloffL. A.: Observations on Sodium D-Thyroxine as a Hypocholesteremic Agent in Persons with Hypercholesteremia with and without Ischemic Heart Disease, Am. J. Med. Sci.243: 458 (Apr.) 1962. (OH).
9.
RobertsS. D.: Effect of Atromid on Requirements of Warfarin, J. Atherosclerosis Res.3: 655 (Sept.–Dec.) 1963.
10.
BarthP.KommerellB.: [Effect of Clofibrate on Blood Coagulation], Med. Klin.61: 1466 (Sept. 16) 1966. (Ger).
11.
KatoR.VassanelliP.ChiesaraE.: Inhibition of Some Microbial Drug-Metabolizing Enzymes by Inhibitors of Cholesterol Biosynthesis, Biochem. Pharmacol.12: 349 (Apr.) 1963.
